Join to View Full Profile
1100 Marshall WayPlacerville, CA 95667
Phone+1 530-622-1441
Fax+1 530-622-7853
Dr. Skratt is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Emergency Medicine, 1993 - 1996
Albany Medical CollegeClass of 1993
Certifications & Licensure
CA State Medical License 1995 - 2026
American Board of Emergency Medicine Emergency Medicine
Publications & Presentations
PubMed
- 5 citationsα-Fluoromethylhistidine-induced inhibition of brain histidine decarboxylase: Implications for the CO2-trapping enzymatic methodJohn J. Skratt, Lindsay B. Hough, Julia W. Nalwalk, Kim E. Barke
Biochemical Pharmacology. 1994-01-20 - 89 citationsProtection against DSP-4-induced neurotoxicity by deprenyl is not related to its inhibition of MAO BKevin T. Finnegan, John J. Skratt, Ian Irwin, Louis E. DeLanney, J. William Langston
European Journal of Pharmacology. 1990-08-02 - 28 citationsThe N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prevents the neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) in rats.Kevin T. Finnegan, John J. Skratt, Ian Irwin, J W Langston
Neuroscience Letters. 1989-11-06
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
